Christian Schnell

11.0k total citations · 1 hit paper
92 papers, 5.0k citations indexed

About

Christian Schnell is a scholar working on Molecular Biology, Geometry and Topology and Mathematical Physics. According to data from OpenAlex, Christian Schnell has authored 92 papers receiving a total of 5.0k indexed citations (citations by other indexed papers that have themselves been cited), including 50 papers in Molecular Biology, 21 papers in Geometry and Topology and 16 papers in Mathematical Physics. Recurrent topics in Christian Schnell's work include PI3K/AKT/mTOR signaling in cancer (22 papers), Algebraic Geometry and Number Theory (20 papers) and Angiogenesis and VEGF in Cancer (17 papers). Christian Schnell is often cited by papers focused on PI3K/AKT/mTOR signaling in cancer (22 papers), Algebraic Geometry and Number Theory (20 papers) and Angiogenesis and VEGF in Cancer (17 papers). Christian Schnell collaborates with scholars based in Switzerland, United States and United Kingdom. Christian Schnell's co-authors include Jeanette M. Wood, Sauveur-Michel Maira, Pascal Furet, Frédéric Stauffer, Christine Fritsch, Saskia M. Brachmann, Josef Brueggen, Carlos García-Echeverría, Terence O’Reilly and Carlos Garcı́a-Echeverrı́a and has published in prestigious journals such as Proceedings of the National Academy of Sciences, Journal of Biological Chemistry and SHILAP Revista de lepidopterología.

In The Last Decade

Christian Schnell

88 papers receiving 4.9k citations

Hit Papers

Identification and characterization of NVP-BEZ235, a new ... 2008 2026 2014 2020 2008 250 500 750
What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

  1. Identification and characterization of NVP-BEZ235, a new orally available dual phosphatidylinositol 3-kinase/mammalian target of rapamycin inhibitor with potent in vivo antitumor activity
    2008 954 citations Sauveur-Michel Maira, Frédéric Stauffer et al. Molecular Cancer Therapeutics profile →

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Christian Schnell Switzerland 33 3.0k 934 554 535 441 92 5.0k
Jianfeng Lü United States 37 3.4k 1.1× 1.2k 1.2× 375 0.7× 378 0.7× 432 1.0× 140 5.6k
Sharon Shacham United States 46 4.4k 1.5× 1.4k 1.5× 500 0.9× 369 0.7× 419 1.0× 221 5.8k
Hannu Haapasalo Finland 39 2.4k 0.8× 854 0.9× 483 0.9× 754 1.4× 1.1k 2.5× 131 4.9k
Hane Lee United States 34 3.7k 1.2× 1.3k 1.4× 277 0.5× 640 1.2× 221 0.5× 86 5.3k
Hajime Hosoi Japan 35 3.1k 1.0× 981 1.1× 835 1.5× 803 1.5× 267 0.6× 189 5.1k
Jun Qi United States 46 7.7k 2.5× 1.8k 1.9× 369 0.7× 698 1.3× 394 0.9× 177 9.3k
Darrell J. Yamashiro United States 42 3.4k 1.1× 942 1.0× 563 1.0× 908 1.7× 309 0.7× 128 5.6k
Christine Le Roy France 33 3.6k 1.2× 650 0.7× 383 0.7× 390 0.7× 166 0.4× 70 5.6k
Jeffrey Lee United States 28 4.0k 1.3× 973 1.0× 335 0.6× 627 1.2× 174 0.4× 84 6.1k
Matthew Mort United Kingdom 33 6.1k 2.0× 394 0.4× 457 0.8× 964 1.8× 420 1.0× 79 9.1k

Countries citing papers authored by Christian Schnell

Since Specialization
Citations

This map shows the geographic impact of Christian Schnell's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Christian Schnell with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Christian Schnell more than expected).

Fields of papers citing papers by Christian Schnell

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Christian Schnell. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Christian Schnell. The network helps show where Christian Schnell may publish in the future.

Co-authorship network of co-authors of Christian Schnell

This figure shows the co-authorship network connecting the top 25 collaborators of Christian Schnell. A scholar is included among the top collaborators of Christian Schnell based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Christian Schnell. Christian Schnell is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Schnell, Christian, et al.. (2026). Higher multiplier ideals. Journal für die reine und angewandte Mathematik (Crelles Journal).
2.
Borrego, Manuel Ruíz, Yen‐Shen Lu, Yeon Hee Park, et al.. (2024). SGLT2 inhibition improves PI3Kα inhibitor–induced hyperglycemia: findings from preclinical animal models and from patients in the BYLieve and SOLAR-1 trials. Breast Cancer Research and Treatment. 208(1). 111–121. 5 indexed citations
3.
Grimm, Thomas W., et al.. (2023). Finiteness for self-dual classes in integral variations of Hodge structure. Special volume in honour of.... 9 indexed citations
4.
Popa, Mihnea & Christian Schnell. (2023). On the behavior of the Kodaira dimension under smooth morphisms. Algebraic geometry. 607–619.
5.
Sodian, Ralf, et al.. (2021). 3-dimensional printing for the diagnosis of left ventricular outflow tract obstruction after mitral valve replacement. Interactive Cardiovascular and Thoracic Surgery. 32(5). 724–726. 1 indexed citations
6.
Schnell, Christian. (2019). Targeted siRNA delivery in vivo. 1 indexed citations
7.
O’Brien, Neil A., Tong Luo, Erika von Euw, et al.. (2014). Targeting PI3K/mTOR Overcomes Resistance to HER2-Targeted Therapy Independent of Feedback Activation of AKT. Clinical Cancer Research. 20(13). 3507–3520. 93 indexed citations
8.
Popa, Mihnea & Christian Schnell. (2013). GENERIC VANISHING THEORY VIA MIXED HODGE MODULES. Forum of Mathematics Sigma. 1. 14 indexed citations
9.
Marone, Romina, Thomas Bohnacker, Christian Schnell, et al.. (2009). Targeting Melanoma with Dual Phosphoinositide 3-Kinase/Mammalian Target of Rapamycin Inhibitors. Molecular Cancer Research. 7(4). 601–613. 92 indexed citations
10.
Lane, Heidi A., Jeanette M. Wood, Paul M.J. McSheehy, et al.. (2009). mTOR Inhibitor RAD001 (Everolimus) Has Antiangiogenic/Vascular Properties Distinct from a VEGFR Tyrosine Kinase Inhibitor. Clinical Cancer Research. 15(5). 1612–1622. 196 indexed citations
11.
Samaržija, Ivana, Fabienne Baffert, Amanda Littlewood‐Evans, et al.. (2008). Inhibition of Multiple Vascular Endothelial Growth Factor Receptors (VEGFR) Blocks Lymph Node Metastases but Inhibition of VEGFR-2 Is Sufficient to Sensitize Tumor Cells to Platinum-Based Chemotherapeutics. Cancer Research. 68(5). 1581–1592. 32 indexed citations
12.
Maira, Sauveur-Michel, Frédéric Stauffer, Josef Brueggen, et al.. (2008). Identification and characterization of NVP-BEZ235, a new orally available dual phosphatidylinositol 3-kinase/mammalian target of rapamycin inhibitor with potent in vivo antitumor activity. Molecular Cancer Therapeutics. 7(7). 1851–1863. 954 indexed citations breakdown →
13.
Schnell, Christian, Frédéric Stauffer, Peter R. Allegrini, et al.. (2008). Effects of the Dual Phosphatidylinositol 3-Kinase/Mammalian Target of Rapamycin Inhibitor NVP-BEZ235 on the Tumor Vasculature: Implications for Clinical Imaging. Cancer Research. 68(16). 6598–6607. 143 indexed citations
14.
Ehrbar, Martin, Steffen M. Zeisberger, G. P. Raeber, et al.. (2008). The role of actively released fibrin-conjugated VEGF for VEGF receptor 2 gene activation and the enhancement of angiogenesis. Biomaterials. 29(11). 1720–1729. 103 indexed citations
15.
Schnell, Christian. (2008). The boundary behavior of cohomology classes and singularities of normal functions. OhioLink ETD Center (Ohio Library and Information Network). 4 indexed citations
16.
17.
O’Reilly, Terence, Jeanette M. Wood, Amanda Littlewood-Evans, et al.. (2005). Differential anti-vascular effects of mTOR or VEGFR pathway inhibition: A rational basis for combining RAD001 and PTK787/ZK222584. Cancer Research. 65. 715–715. 9 indexed citations
18.
19.
Schnell, Christian, et al.. (1993). Comparative Pharmacokinetics of Free Muramyl Tripeptide Phosphatidyl Ethanolamine (MTP-PE) and Liposomal MTP-PE. Journal of Pharmaceutical Sciences. 82(10). 997–1001. 17 indexed citations
20.
Gay, Bernard, Harry Towbin, Christian Schnell, et al.. (1991). Direct chemiluminescence immunoassay (CLIA) for muramyl tripeptide phosphatidyl‐ethanolamine in plasma. Journal of Bioluminescence and Chemiluminescence. 6(2). 73–80. 3 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Jianfeng Lü Breakdown of academic impact, for papers by Sharon Shacham Breakdown of academic impact, for papers by Hannu Haapasalo Breakdown of academic impact, for papers by Hane Lee Breakdown of academic impact, for papers by Hajime Hosoi Breakdown of academic impact, for papers by Jun Qi Breakdown of academic impact, for papers by Darrell J. Yamashiro Breakdown of academic impact, for papers by Christine Le Roy Breakdown of academic impact, for papers by Jeffrey Lee Breakdown of academic impact, for papers by Matthew Mort
Rankless by CCL
2026